Bio Farma Has Distributed 129 Million Vaccine Doses Since January 2021, AstraZeneca Is In The Second Most

Illustration. (Photo: Doc. Antara)

JAKARTA - The holding company for Pharmaceutical SOE, Bio Farma, from January 2021 to August 2021 has distributed 129.891.072 doses of COVID-19 vaccine and the implementation of the COVID-19 distribution is based on the allocation and request from the Ministry of Health.

This COVID-19 vaccine consists of various platforms from several manufacturers, which are obtained directly bilaterally between Bio Farma and producers, as well as through a dose share mechanism between the Indonesian government and other countries.

The total distribution of COVID-19 vaccines consists of 90.368.340 doses of Bio Farma COVID-19, AstraZeneca (Covax, B2B, and Grants) 16.518.784, CoronaVac 1 dose of 3 million doses, Moderna 7.563.318, Coronavac 2 doses 9.990.344 and Sinopharm (grant) as many as 499.886 doses.

The Corporate Secretary and spokesperson for Bio Farma, Bambang Heriyanto, said that his party continues to coordinate with the Ministry of Health to distribute according to the priorities and regional targets that have been set.

In addition to this, in distribution, it is still necessary to pay attention to the availability or stock of vaccines that are ready to be distributed or have received a lot of release from the National Agency of Drug and Food Control (POM).

"Since January, until the end of August 2021, Bio Farma has distributed 129.891.072 doses to all provinces in Indonesia. And during August 2021, Bio Farma has distributed approximately 42.860.100 doses of COVID-19 vaccine and the date September 1, 2021, Bio Farma will distribute 3.064.640 doses to 32 provinces in Indonesia", he said, quoted from Antara, Thursday, September 2.

Bambang added that as of September 2021, the vaccines that are ready to be sent back by Bio Farma to all provinces in Indonesia are 18 million doses.

Then in September, there will be an additional supply of COVID-19 Vaccine from Bio Farma's production of 23.280.000 million doses, as well as an additional 25 million doses of the finished product CoronoVac Vaccine.

And this does not include additional vaccines from the Covax/Gavi multilateral scheme, bilateral and other bilateral donations that will also come during September 2021.

Additional COVID-19 Vaccine Supply

Closing the month of August 2021, Indonesia again received additional vaccine shipments to 43 to 45 in the period August 27 - 30, 2021.

The vaccines include 5 million doses of CoronaVac vaccine (finished product), 1.08 million doses of AstraZeneca vaccine with B2B and 9.2 million doses of bulk COVID-19 vaccine from Sinovac.

In September 2021, Indonesia will receive an additional 2 doses of CoronaVac vaccine in the form of a finished product of 25 million doses of vaccine, as well as additional vaccines from the Covax/Gavi multilateral scheme, bilateral and other bilateral donations.

So it is estimated that the total availability of vaccine stocks in Indonesia for supply in September is expected to reach more than 70 million doses.

The arrival in September began with the entry of the bilateral scheme AstraZeneca Vaccine on September 1, 2021, totaling 583.400 doses.

As of the end of August 2021, Indonesia has secured 217.936.360 doses of the COVID-19 vaccine, with details in the form of 153.900.280 bulk doses and 64.036.080 doses of the finished product.

"The arrival of this vaccine will be followed by the arrival of the next stage of the vaccine. All of this is clear evidence that the government continues to work hard to bring in a COVID-19 vaccine to meet national vaccination needs", said Coordinating Minister for Human Development and Culture of Indonesia Prof. Muhadjir Effendy on Monday, August 30 upon receipt of bulk COVID-19 vaccine from Sinovac.